Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors

Journal of Urology

Volumn 159, Issue 2, 1998, Pages 389-393

  Pode, Dov ^a   Golijanin, Dragan ^a   Sherman, Yoav ^a   Lebensart, Pinhas ^a   Shapiro, Amos ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bladder neoplasms; Immunocytochemistry; Lewis X antigen; Ultrasonography

Indexed keywords

ARTICLE; BLADDER BIOPSY; BLADDER TUMOR; BLOOD GROUP LEWIS SYSTEM; CLINICAL TRIAL; CYSTOSCOPY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE LEVEL;

EID: 0031985233     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63928-4     Document Type: Article

References (19)

1. Catalona, W. J.: Urothelial tumors of the urinary tract. In: Campbell's Urology, 6th ed. Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughan. Philadelphia: W. B. Saunders Co., vol. 2, chapt. 28, pp. 1094-1158, 1992.
2. Koss, G. L., Deitch, D., Ramanathan, R. and Sherman, A. B.: Diagnostic value of cytology of voided urine. Acta Cytol., 29: 810, 1985.
3. Chopin, D. K., deKernion, J. B., Rosenthal, D. L. and Fahey, J. L.: Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J. Urol., 134: 260, 1985.
4. Schmitz-Drager, B. J., Nakamura, S., Decken, K., Pfitzer, P., Rottmann-Ickler, C., Ebert, T. and Ackermann, R.: Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. II. Prospective trial on the diagnostic value of immunocytology using monoclonal antibody Due ABC 3. J. Urol., 146: 1521, 1991.
5. Huland, H., Arndt, R., Huland, E., Loening, T. and Steffens, M.: Monoclonal antibody 286 p 3/12: a valuable bladder carcinoma marker for immunocytology. J. Urol., 137: 654, 1987.
6. Bonner, R. B., Hemstreet, G. P., Fardet, Y., Rao, J. Y., Min, K. W. and Hurst, R. E.: Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells. CA, 72: 2461, 1993.
7. Cordon-Cardo, C., Lloyd, K. O., Finstad, C. L., McGroarty, M. E., Reuter, V. E., Bander, N. E., Old, L. J. and Melamed, M. R.: Immunoanatomic distribution of blood group antigens in the human urinary tract: Influence of secretor ststus. Lab. Invest., 55: 444, 1986.
8. Cordon-Cardo, C., Reuter, V. E., Lloyd, K. O., Sheinfeld, J., Fair, W. R., Old, L. J. and Melamed, M. R.: Blood group related antigens in human urothelium: enhanced expression of precursor, Le X and Le Y determinants in urothelial carcinoma. Cancer Res., 48: 4113, 1988.
9. Sheinfeld, J., Reuter, V. E., Melamed, M. R., Fair, W. R., Morse, M., Sogani, P. C., Herr, H. W., Whitmore, W. F., Jr. and Cordon-Cardo, C.: Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J. Urol., 143: 285, 1990.
10. Golijanin, D., Sherman, Y., Shapiro, A. and Pode, D.: Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine. Urology, 46: 173, 1995.
11. Papanicolaou, G. N. and Marshall, V. F.: Urine sediment smears. A diagnostic procedure in cancers of the urinary tract. Science, 101: 519, 1945.
12. Bales, C. E.: A semi-automated method for preperation of urine sediment for cytologic evaluation. Acta Cytol., 25: 323, 1981.
13. Badalament, R. A., Fair, W. R., Whitmore, W. F., Jr. and Melamed, M. R.: The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. Sem. Urol., 6: 22, 1988.
14. Sarosdy, M. F., deVere White, M. S., Soloway, M. S., Sheinfeld, J., Hudson, M. A., Schellhammer, P. F., Jarowenko, M. V., Adams, G. and Blumenstein, B. A.: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154: 379, 1995.
15. Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., Rukstulis, D. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P. and Hayden, C. L.: Use of new tumor marker, urinary NMP22, in detection of occult or rapidly recurring transitional cell carcinoma of urinary tract following surgical treatment. J. Urol., 156: 363, 1996.
16. Berlac, P. A. and Holm, H. R.: Bladder tumor control by abdominal ultrasound and urine cytology. J. Urol., 147: 1510, 1992.
17. Fardet, Y., Cordon-Cardo, C., Whitmore, W. F., Jr., Melamed, M. R. and Old, L. J.: Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. Cancer Res., 46: 5183, 1986.
18. Fardet, Y.: Markers of prognosis in superficial bladder cancer. Sem. Urol., 10: 28, 1992.
19. Sagerman, P. M., Saigo, P. E., Sheinfeld, J., Chritonowics, E. and Cordon-Cardo, C.: Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens. Acta Cytol., 38: 517, 1994.